Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes
|
By HospiMedica International staff writers Posted on 16 Nov 2022 |

Absology Co., Ltd. (Gyeonggi-do, Korea) is participating in MEDICA 2022 where the company is exhibiting its POC FIA (Fluorescence Immunoassay) analyzer that uses microfluidic technology for the accurate quantitative diagnosis of concentration of biomarkers for a range of diseases.
At MEDICA 2022, Absology is showcasing its ABSOL POCT analyzer that uses FIA technology to quantitatively diagnose the concentration of biomarkers. It has a test time of only five minutes and features a vivid expressed GUI along with a convenient built-in printer. Alongside ABSOL, the company is showcasing the ABSOL HS high-sensitive ELISA analyzer for early disease screening. ABSOL HS can detect Femtogram level molecules using Absology’s proprietary PIFA (Photooxidation Induced Fluorescence Amplification) technology. It has a test time of only 30 minutes and requires just 20uL of blood sample. Compact and affordable, the portable and light weight ABSOL HS is a flexible platform for any kind of ELISA protocol. Absology offers a wide test menu for the ABSOL and ABSOL HS systems, including PSA, Testosterone, Vitamin D, TSH, FreeT4, Thyroid Combo, Cortisol, PCT, COVID-19 IgM/IgG, COVID-19 Ag, COVID-19 Neutralizing Antibody, and Influenza A/B.
Related Links:
Absology Co., Ltd.
Latest MEDICA 2022 News
Channels
Artificial Intelligence
view channelCritical Care
view channel
New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
Drug-resistant infections such as methicillin-resistant Staphylococcus aureus pose a serious treatment challenge, often requiring powerful antibiotics that can damage vital organs when delivered through... Read more
Intelligent Camera System Continuously Monitors Premature Babies in NICU
The neonatal period is a critical stage of life, with premature babies facing a higher risk of short- and long-term complications that require close observation. In neonatal intensive care units (NICUs),... Read moreSurgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







.jpg)
